Related Experiment Video
Updated: Aug 14, 2026
14:06
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
Published on: June 23, 2012
Analysis of SNPs in pooled DNA: a decision theoretic model
Inke R König1, Andreas Ziegler
1Centre for Genetic Epidemiological Methods, Institute of Medical Biometry and Statistics, University at Lübeck, Lübeck, Germany.
Genetic Epidemiology
|December 24, 2003
Summary
This study introduces a new algorithm to optimize two-stage genotyping for complex diseases using single nucleotide polymorphisms (SNPs). The approach reduces genotyping costs and rates while maintaining acceptable error rates in case-control studies.
Area of Science:
- Genetics
- Bioinformatics
- Statistical Genetics
Background:
- Complex diseases require extensive genetic analysis using single nucleotide polymorphisms (SNPs).
- Two-stage genotyping, involving pooled DNA analysis followed by individual genotyping, is used to reduce costs in SNP studies.
- A well-founded algorithm is lacking to guide decisions on individual SNP genotyping after pooled analysis.
Purpose of the Study:
- To develop an optimal decision algorithm for individual genotyping based on pooled DNA analysis results.
- To provide decision criteria for researchers to optimize genotyping strategies in case-control studies.
- To reduce genotyping rates and associated costs while maintaining acceptable error rates.
Main Methods:
- Modeling the genotyping decision as a decision process.
- Developing and presenting different loss functions and decision rules.
- Utilizing Monte-Carlo simulations to evaluate the algorithm's performance.
Main Results:
- The proposed approach provides an algorithm for optimal individual genotyping decisions.
- Monte-Carlo simulations demonstrate significant reductions in genotyping rates and costs.
- The method maintains acceptable overall error rates for case-control studies.
Conclusions:
- The developed algorithm effectively guides individual genotyping decisions in two-stage SNP analysis.
- This approach offers a cost-effective strategy for genetic studies of complex diseases.
- The findings enable researchers to optimize resource allocation in large-scale genetic research.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:09Decision Making: P-value Method
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...